Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
13.88
-0.11 (-0.79%)
At close: Mar 4, 2026, 4:00 PM EST
13.88
0.00 (0.00%)
After-hours: Mar 4, 2026, 7:00 PM EST

Avanos Medical Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for Avanos Medical in the last 12 months.

Price Target: n/a
Analyst Consensus: n/a
TargetLowAverageMedianHigh
Pricen/an/an/an/a
Changen/an/an/an/a

Analyst Ratings

There are currently no analyst ratings available for Avanos Medical.

Recommendation Trends

RatingDec '23Jan '24Feb '24Mar '24Apr '24May '24
Strong Buy111110
Buy000000
Hold222220
Sell111110
Strong Sell000000
Total444440

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
JMP Securities
JMP Securities
Hold
Reiterates
n/a
HoldReiteratesn/an/aMay 7, 2024
Keybanc
Keybanc
Hold
Downgrades
n/a
HoldDowngradesn/an/aJul 25, 2023
Stifel
Stifel
Hold
Reiterates
$25
HoldReiterates$25+80.12%Jun 21, 2023
CL King
CL King
Strong Buy
Initiates
$31
Strong BuyInitiates$31+123.34%May 22, 2023
Morgan Stanley
Morgan Stanley
Sell
Maintains
$28$26
SellMaintains$28$26+87.32%May 4, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
724.20M
from 701.20M
Increased by 3.28%
Revenue Next Year
754.80M
from 724.20M
Increased by 4.23%
EPS This Year
0.97
from -1.57
EPS Next Year
1.46
from 0.97
Increased by 50.53%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
587.00M684.10M673.30M687.80M701.20M724.20M754.80M
Revenue Growth
-17.88%16.54%-1.58%2.15%1.95%3.28%4.23%
EPS
0.131.08-1.33-8.53-1.570.971.46
EPS Growth
-722.10%----50.53%
Forward PE
-----14.329.52
No. Analysts
-----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027
High745.5M777.0M
Avg724.2M754.8M
Low695.8M725.2M

Revenue Growth

Revenue Growth20262027
High
6.3%
7.3%
Avg
3.3%
4.2%
Low
-0.8%
0.1%

EPS Forecast

EPS20262027
High1.001.50
Avg0.971.46
Low0.931.40

EPS Growth

EPS Growth20262027
High-
55.0%
Avg-
50.5%
Low-
44.6%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.